USD10
PBYI Shares
About Puma BiotechnologyPuma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
USD10
PBYI Shares
About Puma BiotechnologyPuma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$434.17M
OPEN PRICE
$8.28
LOW (1Y)
$3.03
HIGH (1Y)
$8.66
LOW (24H)
$8.25
HIGH (24H)
$8.64
VOLUME (24H)
$256.26K
35.97%
Price history
Time | Price | Change |
|---|---|---|
Today | $8.28 | |
1 Day | $8.30 | |
1 Week | $7.95 | |
1 Month | $7.39 | |
1 Year | $3.41 |
Past performance is not a reliable indicator of future results.
Discover more
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.